Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03868579 · ClinicalTrials.gov registry record · NA
Rapid On Site Evaluation of Pleural Touch Preparations in Diagnosing Malignant Pleural Effusion in Patients Undergoing Pleuroscopy
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
NCT03868579: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT03868579 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 97 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03868579, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
Study Summary
This trial studies how well rapid on site evaluation of pleural touch preparations works in diagnosing cancerous fluid in between the linings of the lungs (malignant pleural effusion) in patients undergoing a pleuroscopy. A type of laboratory testing called rapid on site evaluation of pleural touch preparations that uses pleural biopsy tissue samples collected during an already-scheduled pleuroscopy may be able to diagnose malignant pleural effusion.
Interventions
- PROCEDURE Biopsy
- OTHER Medical Chart Review
- PROCEDURE Thoracoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2018-01-10 |
| Est. Completion | 2025-02-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03868579
The ClinicalTrials.gov registry entry for NCT03868579 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Biopsy is the first listed.
NCT03868579 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03868579 about?
NCT03868579 is a clinical study titled "Rapid On Site Evaluation of Pleural Touch Preparations in Diagnosing Malignant Pleural Effusion in Patients Undergoing Pleuroscopy". This trial studies how well rapid on site evaluation of pleural touch preparations works in diagnosing cancerous fluid in between the linings of the lungs (malignant pleural effusion) in patients undergoing a pleuroscopy. A type of laboratory testing called rapid on site evaluation of pleural touch ...
What is the current status of trial NCT03868579?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2018-01-10. Estimated completion is 2025-02-27.
What interventions are being tested in trial NCT03868579?
The interventions under investigation include: Biopsy (PROCEDURE), Medical Chart Review (OTHER), Thoracoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT03868579?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.